Found: 122
Select item for more details and to access through your institution.
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 2, p. 1, doi. 10.1093/ofid/ofad637
- By:
- Publication type:
- Article
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad517
- By:
- Publication type:
- Article
Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.
- Published in:
- American Journal of Public Health, 2020, v. 110, n. 1, p. 45, doi. 10.2105/AJPH.2019.305379
- By:
- Publication type:
- Article
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. 2037, doi. 10.1093/cid/ciab526
- By:
- Publication type:
- Article
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. e107, doi. 10.1093/cid/ciaa612
- By:
- Publication type:
- Article
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. e69, doi. 10.1093/cid/ciaa571
- By:
- Publication type:
- Article
Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 1, p. 123, doi. 10.1093/cid/ciz162
- By:
- Publication type:
- Article
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2218, doi. 10.1093/cid/ciz714
- By:
- Publication type:
- Article
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
- Published in:
- Harm Reduction Journal, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12954-021-00494-4
- By:
- Publication type:
- Article
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-08989-8
- By:
- Publication type:
- Article
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.
- Published in:
- Addiction, 2014, v. 109, n. 12, p. 2053, doi. 10.1111/add.12682
- By:
- Publication type:
- Article
Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257369
- By:
- Publication type:
- Article
Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 1, p. 20, doi. 10.1093/cid/cix768
- By:
- Publication type:
- Article
Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 7, p. 860, doi. 10.1093/cid/ciw869
- By:
- Publication type:
- Article
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1479, doi. 10.1093/cid/ciw579
- By:
- Publication type:
- Article
Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1405, doi. 10.1093/cid/ciw580
- By:
- Publication type:
- Article
Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 7, p. 1014, doi. 10.1093/cid/cit377
- By:
- Publication type:
- Article
Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. S62
- By:
- Publication type:
- Article
Moving the Agenda Forward: The Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. S29, doi. 10.1093/cid/cit264
- By:
- Publication type:
- Article
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. S129
- By:
- Publication type:
- Article
Directly Observed Pegylated Interferon Plus Self-Administered Ribavirin for the Treatment of Hepatitis C Virus Infection in People Actively Using Drugs: A Randomized Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. S90, doi. 10.1093/cid/cit327
- By:
- Publication type:
- Article
Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. S80, doi. 10.1093/cid/cit306
- By:
- Publication type:
- Article
Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 569, doi. 10.1111/liv.15469
- By:
- Publication type:
- Article
Creating an environment for equitable access to direct‐acting antiviral therapy for people who inject drugs with hepatitis C.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2353, doi. 10.1111/liv.14661
- By:
- Publication type:
- Article
Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 778, doi. 10.1111/liv.14266
- By:
- Publication type:
- Article
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 20, doi. 10.1111/liv.13949
- By:
- Publication type:
- Article
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection.
- Published in:
- Liver International, 2016, v. 36, n. 12, p. 1774, doi. 10.1111/liv.13176
- By:
- Publication type:
- Article
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy248
- By:
- Publication type:
- Article
Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 2, p. N.PAG, doi. 10.1093/ofid/ofy001
- By:
- Publication type:
- Article
The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2016, p. 1, doi. 10.1155/2016/7603526
- By:
- Publication type:
- Article
Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2016, p. 1, doi. 10.1155/2016/5743521
- By:
- Publication type:
- Article
Health-related quality of life among people who inject drugs in Australia.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 11, p. 3195, doi. 10.1007/s11136-023-03465-3
- By:
- Publication type:
- Article
Incidence of hepatitis C virus infection in the prison setting: The SToP‐C study.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 1, p. 21, doi. 10.1111/jvh.13895
- By:
- Publication type:
- Article
Hepatitis C care cascade before and during the direct‐acting antiviral eras in New South Wales, Australia: A population‐based linkage study.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 3, p. 250, doi. 10.1111/jvh.13791
- By:
- Publication type:
- Article
Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 1, p. 64, doi. 10.1111/jvh.13761
- By:
- Publication type:
- Article
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta‐analysis.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 10, p. 1340, doi. 10.1111/jvh.13574
- By:
- Publication type:
- Article
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 281, doi. 10.1111/jvh.13233
- By:
- Publication type:
- Article
Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 12, p. 1423, doi. 10.1111/jvh.13196
- By:
- Publication type:
- Article
Modelling the potential prevention benefits of a treat‐all hepatitis C treatment strategy at global, regional and country levels: A modelling study.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 12, p. 1388, doi. 10.1111/jvh.13187
- By:
- Publication type:
- Article
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 9, p. 1094, doi. 10.1111/jvh.13119
- By:
- Publication type:
- Article
Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 8, p. 969, doi. 10.1111/jvh.13112
- By:
- Publication type:
- Article
Genomic variability of within‐host hepatitis C variants in acute infection.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 4, p. 476, doi. 10.1111/jvh.13051
- By:
- Publication type:
- Article
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 1, p. 83, doi. 10.1111/jvh.13013
- By:
- Publication type:
- Article
Understanding facilitators and barriers of direct‐acting antiviral therapy for hepatitis C virus infection in prison.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1526, doi. 10.1111/jvh.12987
- By:
- Publication type:
- Article
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population‐based study.
- Published in:
- Drug & Alcohol Review, 2024, v. 43, n. 5, p. 1080, doi. 10.1111/dar.13688
- By:
- Publication type:
- Article